Anne Marie Reimer Jensen

PhD student at @CTCPR_ Doing research in cardiology, echocardiography, aging and HIV 🫀

[Mats C. Højbjerg Lassen, MD @matslassen]

👵👴 In a pragmatic 🇩🇰 RCT of 131k adults ≥60y, RSVpreF vaccine 💉 reduced:
➡️ RSV hosp by 83%
➡️ LRTD hosp by 92%
➡️ All-cause RTD hosp by 15%
Safety ✅

Presented today at #ESCCongress 🫀🫁
Out now in @NEJM
https://t.co/bQfLBQy9P5
@TorBiering @CTCPR_

[Niklas Dyrby Johansen @niklasdj1]

DANFLU-2 presented by @TorBiering at #ESCCongress today! Monumental 3-year effort by everyone involved!

Out now in @NEJM: https://t.co/m2Hjz4ua2d

No sig ⬇️ in hosp for composite of flu or pneumonia, but lower incidence of hosp for cardio-resp disease and flu alone ♥️🫁

[Circ: Heart Failure @CircHF]

In DANFLU-2, high-dose vs standard-dose flu vaccine was associated with 20% lower HF hospitalizations in >10k with HF and >322k without HF @KristofferSkaarup @TorBiering @niklasdj1 @CTCPR_ @matslassen @AM_reimer @fdavidovski_MD @dons_maria
https://t.co/8f65FZYT3U

[Niklas Dyrby Johansen @niklasdj1]

The countdown is on! DANFLU-2 will be presented at #ESCCongress on Saturday!

332,438 adults ≥65 years 👵👴
High-dose vs standard-dose influenza vaccine 💉
Severe outcomes: hospitalizations and deaths 🏥☠️

Design paper: https://t.co/BcqEe1xT8I

Look out for simpubs! 👀

[Mats C. Højbjerg Lassen, MD @matslassen]

🚨 Coming up Saturday at #ESCCongress 🚨
Main results from the DAN-RSV trial 👵👴 (n=131,379; age ≥60)

💉 RSVpreF vaccine vs no vaccine
🏥 Outcomes: RSV-related and all-cause hospitalizations

Big news for RSV prevention - 👀 out for simpubs!

design 📄: https://t.co/W8JZZdtTEa

[Circulation @CircAHA]

In Denmark, CVD affects 11% of the population—but with universal healthcare, registry-based research, and bold public health moves, outcomes are improving. Equity is the next frontier. ❤️ @AM_reimer @Espersen_C @TorBiering https://t.co/GirP5MOUrb

[CTCPR Trials & CIRL @CTCPR_]

Findings by @matslassen from @CTCPR_ High-dose flu vaccine (QIV-HD) reduced all-cause hospitalizations in adults 65-79, with or without diabetes. In those with diabetes, it also lowered the risk of death + hospitalization for pneumonia/influenza.
https://t.co/mvjvgBrDP5

[CTCPR Trials & CIRL @CTCPR_]

@CTCPR_ is hiring!
We’re looking for a passionate project nurse to join our research team.
https://t.co/g7O7TywN3n

[CTCPR Trials & CIRL @CTCPR_]

Elevated plasma apolipoprotein E (apoE) levels in people living with HIV: strong links with biomarkers and HIV-specific risk factors. Study by @AM_reimer from @CTCPR_ highlights the need for further research. #HIV
https://t.co/8E2Ad6u8oh

[Atherosclerosis @ATHjournal]

PWH had higher plasma apoE than controls even after adjusting for triglycerides. Further studies are needed to elucidate the clinical impact of high plasma apoE in PWH
🔗https://t.co/s1x3w0wogH
@BNordestgaard @society_eas @ELS_Cardiology

[Anne Marie Reimer Jensen @AM_reimer]

People with HIV have higher plasma levels of apolipoprotein E than controls from the general population and this association is independent of both apolipotein B and triglyceride levels.

First PhD-article published in @ATHjournal

https://t.co/o75Hvx4FC0

[Anne Marie Reimer Jensen @AM_reimer]

In people with #HIV, 📉low NT-proBNP is associated with an adverse adipose tissue profile—high BMI, central obesity, VAT accumulation and low adiponectin.

Check out the newly published article by my mentee, Mads-Holger Bang Jacobsen: https://t.co/vpQiNVlkvs

@RigsHeart @CopCard

[Anne Marie Reimer Jensen @AM_reimer]

I will present my abstract “Proteomic Associations of Cardiac Function Trajectories Through Mid- to Late Life” on Sat Nov 11 at 3:00-4:15 pm and hope to see you there!

Details available here:
https://t.co/ptetg56mRT #AHA23

[Anne Marie Reimer Jensen @AM_reimer]

I am honored to be recognized along with my coauthors at #AHA23 for the highest ranked abstract from Denmark. A special thanks to my mentors, Prof. @TorBiering and Prof. Amil Shah, for their invaluable help along the way!

[Anne Marie Reimer Jensen @AM_reimer]

Results from proteomic analyses looking at biologic differences according to predicted trajectory membership will be presented later this year at #AHA23

[Anne Marie Reimer Jensen @AM_reimer]

Bayesian modelling can identify multidimensionel trajectories of cardiac function that associate differentially with risk of #HFpEF and #HFrEF. This approach has the potential to improve HF risk prediction in the future

#ESCCongress2023 #ESCCongress @CIRL_DK @BrighamResearch

[Anne Marie Reimer Jensen @AM_reimer]

Happy to present results from this study early this morning. The poster and presentation is available on the ESC online platform: https://t.co/7i2cPfk243

[Anne Marie Reimer Jensen @AM_reimer]

“When we account for LVEF, things get interesting!”

Amazing presentation by @fdavidovski_MD about the prognostic value of AS in HFrEF.

#ESCCongress @CIRL_DK @CopCard @TorBiering

[Anne Marie Reimer Jensen @AM_reimer]

Grateful and proud to be part og Prof. @TorBiering’s incredible team @CIRL_DK. It has been an honor to participate in the groundbreaking and innovative DANFLU trial 💫

[Niklas Dyrby Johansen @niklasdj1]

Our guiding light @TorBiering with a tour de force on how we can use administrative health registries to conduct streamlined pragmatic trials, greatly exemplified by our #DANFLU and #NUDGE #NUDGEFLU programs with much more to come!